University of Hawaii Cancer Center CCSG
University of Hawaii Cancer Center CCSG
批准号:
10426156
负责人:
Naoto T Ueno
金额:
$215.6万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-07-01 至 2024-06-30
关键词:
AddressAnalytical BiochemistryAppointmentAreaBioinformaticsBiologicalBiometryBiostatistics Shared ResourceBudgetsCancer BiologyCancer BurdenCancer CenterCancer Center Support GrantCancer ControlCancer EtiologyCancer PatientCancer Research ProjectCancer ScienceCatchment AreaCharacteristicsChemopreventionClinicalClinical ResearchClinical TrialsCollaborationsCommunitiesCommunity Health EducationCommunity NetworksCommunity OutreachCommunity TrialComputational BiologyEducationEnvironmentEthnic groupEvaluationFacultyFaculty RecruitmentFinancial SupportFoundationsFundingFutureGenomicsGoalsGrantGuamHawaiiHealthHealth systemHealthcareHigh-Risk CancerIndividualInflammationInfrastructureInstitutionInterventionIntervention TrialInvestigationInvestmentsLocationMalignant NeoplasmsMedicalMissionNative HawaiianNatural ProductsNatural ResourcesNetwork-basedNutsObesityOutcomePacific IslanderPatient CarePatientsPeer ReviewPersonsPoliciesPolicy MakerPopulationPopulation ResearchPopulation SciencesPreventionPrevention approachPrevention trialProcessPublic HealthPublic Health PracticePublic PolicyPublicationsRaceResearchResearch ActivityResearch DesignResearch PersonnelResource SharingRisk AssessmentScienceStatutes and LawsStrategic PlanningStructureSystemTranslatingTranslationsUniversitiesVulnerable Populationsanticancer researchauthoritybasecancer clinical trialcancer health disparitycancer preventioncancer riskcancer therapycarcinogenesisclinical trial enrollmentcommunity engagementdesigndrug discoveryearly phase clinical trialethnic diversityethnic minorityhealth care deliveryhealth disparityinnovationinter-institutionalinterdisciplinary collaborationmedical schoolsmembermetabolomicsmicrobiomemortalitynovelnovel strategiesnutritionoperationoutreachpopulation basedprogramsracial diversityracial minorityrecruitresearch facilitysquare foot
中文摘要
摘要
夏威夷大学癌症中心的使命是通过以下方式减轻癌症负担
研究、教育、病人护理和社区推广,强调独特的种族、文化和
夏威夷和太平洋的环境特征。为了完成这一使命,UCC被组织成
两个癌症研究项目:太平洋人口科学(PSP)和癌症生物学(CB)。
每个项目都由两个部分组成,跨越基本机制和病因的研究。
癌症到解决目标和干预措施,以便将发现转化为它所服务的人群。在
其项目,UCC拥有坚实的癌症研究基础,拥有超过1500万美元的同行评议资金,
其中72.5%来自NCI。PSP有28个正式会员,CB有20个正式会员,他们都是
方案内和方案间以及机构间研究的高比例证明了这一点
合作和出版。为了促进研究目标的成功实现,UCC支持五个
共享资源:生物统计学、基因组学和生物信息学、分析生物化学、营养学
支持和新陈代谢学。UCC服务于夏威夷独特的种族多元化集水区
太平洋独特的环境和丰富的自然资源。这推动了UCC对种族多样性和
癌症、研究和社区参与,旨在解决重大的癌症健康问题
在特定人群中,包括夏威夷土著居民之间的差异。研究项目、社区教育、
公共卫生和临床试验干预措施针对集水区的重要癌症和
基本调查包括对药物发现研究环境中的化合物进行评估。一个
建立了独特的、基于社区网络的临床研究企业,通过这些企业
为超过70%的夏威夷人口提供癌症临床试验;这在一定程度上得到了
UCC牵头的三个相互竞争的卫生系统的联合,作为一个支持UCC的合作企业。癌
与关岛大学和其他机构合作,太平洋各地的预防活动取得了重大进展
对癌症控制的影响,并导致形成了UCC领导的跨太平洋癌症伙伴关系
预防。UCC在该地区的重要性体现在其对癌症控制的重大影响上
立法和国家癌症政策。夏威夷大学(UH)已经对UCC进行了大量投资。
随着招聘新主任,UH重申了主任对教员任命的直接权力,并
187,000平方米的事务、中心预算和业务以及空间分配。英国《金融时报》癌症中心大楼。这个
大学、州长和州政府为运营提供了更多的财政支持,并授权
大量招聘教师,以加强现有计划并启动新的计划,通过
UCC的战略规划进程支持其减轻癌症负担的使命。
英文摘要
ABSTRACT
The mission of the University of Hawai‘i Cancer Center (UHCC) is to reduce the burden of cancer through
research, education, patient care and community outreach with an emphasis on the unique ethnic, cultural and
environmental characteristics of Hawai‘i and the Pacific. To accomplish this mission, UHCC is organized into
two cancer research programs: Population Sciences in the Pacific (PSP) and Cancer Biology (CB).
Programs are each organized with two components spanning the study of basic mechanism and etiologies of
cancer to addressing targets and interventions in order to translate discovery to the population it serves. Within
its programs, UHCC has a strong foundation of cancer research with over $15 million in peer-reviewed funding,
72.5% of which is from the NCI. PSP has 28 full members and CB has 20 full members who are highly
collaborative as evidenced by a high percentage of intra- and inter-programmatic, and inter-institutional, research
collaborations and publications. To facilitate successful attainment of research goals, UHCC supports five
shared resources: Biostatistics, Genomics and Bioinformatics, Analytical Biochemistry, Nutrition
Support, and Metabolomics. UHCC serves a unique ethnically diverse catchment area in Hawai‘i and the
Pacific and a unique environment rich in natural resources. This drives UHCC’s focus on ethnic diversity and
cancer and research and community engagement directed toward addressing significant cancer health
disparities among specific populations, including Native Hawaiians. Research programs, community education,
public health and clinical trial interventions are targeted toward cancers of importance in the catchment area and
basic investigations include evaluation of compounds from the environment for drug discovery research. A
unique, community-network based clinical research enterprise has been established through which UHCC
provides access to cancer clinical trials for over 70% of the Hawai‘i population; this is supported in part by a
UHCC-led affiliation of three competing health systems as a cooperative venture supporting UHCC. Cancer
prevention activities across the Pacific, in collaboration with the University of Guam and others, have had major
impact on cancer control and have led to the formation of the UHCC-led Trans-Pacific Partnership for Cancer
Prevention. The importance of UHCC in the region is exemplified by its significant impact on cancer control
legislation and State cancer policy. The University of Hawai‘i (UH) has made significant investments in UHCC.
With the recruitment new Director, UH reaffirmed the Director’s direct authority over faculty appointments and
affairs, Center budget and operations, and space allocation in the 187,000 sq. ft. Cancer Center building. The
University, Governor and State have provided increased financial support for operations and authorized
numerous faculty recruitments to strengthen existing programs and embark on new initiatives informed through
the UHCC strategic planning process in support of its mission to reduce the burden of cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
University of Hawaii Cancer Center CCSG
-
批准号:10837568
-
项目类别:
-
资助金额:$219.1万
-
财政年份:2023
-
负责人:Naoto T Ueno
-
依托单位:
Developing a novel combination immunotherapy for triple-negative breast cancer
-
批准号:10734197
-
项目类别:
-
资助金额:$66.49万
-
财政年份:2023
-
负责人:Naoto T Ueno
-
依托单位:
Development of a novel therapy targeting the tumor microenvironment in inflammatory breast cancer
-
批准号:10836263
-
项目类别:
-
资助金额:$58.15万
-
财政年份:2022
-
负责人:Naoto T Ueno
-
依托单位:
Development of a novel therapy targeting the tumor microenvironment in inflammatory breast cancer
-
批准号:10390676
-
项目类别:
-
资助金额:$53.68万
-
财政年份:2022
-
负责人:Naoto T Ueno
-
依托单位:
Development of PEA 15 as a Targeted Therapeutic Gene for Ovarian Cancer
-
批准号:8146139
-
项目类别:
-
资助金额:$28.38万
-
财政年份:2007
-
负责人:Naoto T Ueno
-
依托单位:
Markers of sensivity to the EGFR inhibitor erlotinib in breast cancer
-
批准号:8265321
-
项目类别:
-
资助金额:$25.24万
-
财政年份:2007
-
负责人:Naoto T Ueno
-
依托单位:
Markers of sensivity to the EGFR inhibitor erlotinib in breast cancer
-
批准号:7630446
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:Naoto T Ueno
-
依托单位:
Markers of sensivity to the EGFR inhibitor erlotinib in breast cancer
-
批准号:7252750
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:Naoto T Ueno
-
依托单位:
Development of PEA 15 as a Targeted Therapeutic Gene for Ovarian Cancer
-
批准号:7500877
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:Naoto T Ueno
-
依托单位:
Markers of sensivity to the EGFR inhibitor erlotinib in breast cancer
-
批准号:7462422
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:Naoto T Ueno
-
依托单位:
Development of PEA 15 as a Targeted Therapeutic Gene for Ovarian Cancer
-
批准号:7894611
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:Naoto T Ueno
-
依托单位:
Markers of sensivity to the EGFR inhibitor erlotinib in breast cancer
-
批准号:8110494
-
项目类别:
-
资助金额:$31.53万
-
财政年份:2007
-
负责人:Naoto T Ueno
-
依托单位:
Development of PEA 15 as a Targeted Therapeutic Gene for Ovarian Cancer
-
批准号:7372347
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:Naoto T Ueno
-
依托单位:
Development of PEA 15 as a Targeted Therapeutic Gene for Ovarian Cancer
-
批准号:7666914
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:Naoto T Ueno
-
依托单位:
ADENOVIRUS E1A AS A THERAPEUTIC AGENT IN BREAST CANCER
-
批准号:2896273
-
项目类别:
-
资助金额:$7.99万
-
财政年份:1998
-
负责人:Naoto T Ueno
-
依托单位:
ADENOVIRUS E1A AS A THERAPEUTIC AGENT IN BREAST CANCER
-
批准号:2688026
-
项目类别:
-
资助金额:$7.98万
-
财政年份:1998
-
负责人:Naoto T Ueno
-
依托单位:
ADENOVIRUS E1A AS A THERAPEUTIC AGENT IN BREAST CANCER
-
批准号:6376596
-
项目类别:
-
资助金额:$9.05万
-
财政年份:1998
-
负责人:Naoto T Ueno
-
依托单位:
ADENOVIRUS E1A AS A THERAPEUTIC AGENT IN BREAST CANCER
-
批准号:6173388
-
项目类别:
-
资助金额:$9.05万
-
财政年份:1998
-
负责人:Naoto T Ueno
-
依托单位:
ADENOVIRUS E1A AS A THERAPEUTIC AGENT IN BREAST CANCER
-
批准号:6522407
-
项目类别:
-
资助金额:$9.05万
-
财政年份:1998
-
负责人:Naoto T Ueno
-
依托单位:
University of Hawaii Cancer Center CCSG
-
批准号:10514716
-
项目类别:
-
资助金额:$11.5万
-
财政年份:1997
-
负责人:Naoto T Ueno
-
依托单位:
海外基金